Activation of the 5-HT7 receptor but not nitric oxide synthase is necessary for chronic 5-hydroxytryptamine-induced hypotension

Exp Physiol. 2020 Dec;105(12):2025-2032. doi: 10.1113/EP088919. Epub 2020 Oct 22.

Abstract

New findings: What is the central question of this study? What mechanisms account for the hypotension observed during chronic elevations in circulating 5-hydroxytryptamine in rats? What is the main finding and its importance? Chronic 5-hydroxytryptamine-induced hypotension requires continued activation of the 5-HT7 receptor subtype but does not require NO, an outcome that resolves previous conflicting results. Therapeutic interruption of the hypotensive actions of 5-HT under pathophysiological conditions can only be achieved through blockade of the 5-HT7 receptor.

Abstract: Low dose infusion of 5-hydroxytryptamine (5-HT) to rats causes both an acute and a chronic fall in arterial blood pressure. The 5-HT7 receptor subtype plays a critical part in the observed hypotension. Acute (minutes to hours) 5-HT infusion shows no depressor role for nitric oxide (NO), but 5-HT depressor responses under chronic conditions suggest that NO production may be critical. We test the hypothesis that NO contributes to the chronic, but not the acute, depressor response to 5-HT. We compared the role of NO and 5-HT7 receptors in 5-HT-induced hypotension under acute and chronic conditions in the same animal. Mean arterial pressure and heart rate were measured by radiotelemetry in conscious rats during 5 days of saline or 5-HT (25 μg kg-1 min-1 ; osmotic pump) infusion and for 2 days after infusion was stopped. To quantify the contributions of NO and the 5-HT7 receptor to 5-HT-induced hypotension, the nitric oxide synthase (NOS) inhibitor l-NAME or the selective 5-HT7 receptor antagonist SB-267790 were given at 1, 3 and 5 days of chronic infusion, and 1 day after 5-HT infusion pumps were removed. Nω -Nitro-l-arginine methyl ester (l-NAME) caused a pressor response of the same magnitude in the absence or presence of 5-HT infusion. Conversely, SB-269970 did not affect mean arterial pressure in the absence of 5-HT infusion and reversed the 5-HT-induced depressor response at each time point. Our findings demonstrate that acute and chronic 5-HT-induced hypotension does not require NOS activation but does require continued activation of the 5-HT7 receptor.

Keywords: 5-HT; 5-HT7 receptor; hypotension; nitric oxide synthase.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / analogs & derivatives
  • Arginine / metabolism
  • Arterial Pressure / drug effects
  • Blood Pressure / drug effects
  • Enzyme Inhibitors / pharmacology
  • Heart Rate / drug effects
  • Hypotension / chemically induced*
  • Hypotension / metabolism*
  • Male
  • NG-Nitroarginine Methyl Ester / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Serotonin / metabolism*
  • Serotonin / metabolism*
  • Vasoconstrictor Agents / pharmacology

Substances

  • Enzyme Inhibitors
  • Receptors, Serotonin
  • Vasoconstrictor Agents
  • serotonin 7 receptor
  • arginine methyl ester
  • Nitric Oxide
  • Serotonin
  • Arginine
  • Nitric Oxide Synthase
  • NG-Nitroarginine Methyl Ester